Location: Home
  • search
  • go
  • Relate News
  • 12/7/2020Takeda Granted Chinese Approval of HAE Drug TAKHZYRO (Lanadelumab)
  • 12/7/2020BeiGene Announces Chinese Approval of BLINCYTO (Blinatumomab) 
  • 12/7/2020Nabriva and Sinovant Restructure License Deal for XENLETA for CABP i...
  • 12/7/2020Antengene Files Chinese IND for ATG-010 (Selinexor) in Combo with R-G...
  • 12/7/2020How Alibaba and JD.com Compare in Their Healthcare Endeavors
  • 12/6/2020CANbridge Pharmaceuticals Completes $43 Million Series E Financing
  • 12/4/2020Recent Executive Moves
  • 12/3/2020CDE Issues the Technical Guidelines for Clinical Communications Before...
  • 12/3/2020NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance Q...
  • 12/3/2020Ascentage Pharma to Start Leukaemia Therapy Trial in US and China
  • 12/3/2020Chinese Researcher Pleads Guilty to False Statements Relating to Steal...
  • 12/2/2020JW to Conduct Clinical Trials of Gout Treatment in China
  • 12/2/2020LG Chem and TransThera Announce FDA Clearance of IND for SSAO/VAP-1 I...
  • 12/2/2020MSD Secures Chinese Approval of HIV Drug Pifeltro (Doravirine)
  • 12/2/2020Beijing Strengthens Medical Ethics Review with Mutual Recognition Alli...
  • 12/2/2020Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
  • 12/2/2020Etherna and China Grand Pharma Set Up Joint Venture to Tap into mRNA V...
  • 12/1/2020China Initiates Mutual Access Program for Biotech Investors in Hong Ko...
  • 12/1/2020Cedilla and HitGen Announce Research Deal on DNA-Encoded Library Base...
  • 12/1/2020Helsinn and Kyowa Kirin AP Sign Deal for MF-CTCL Topical Drug Valchlo...
  • 12/1/2020NMPA and ANVISA Sign MoU on Cooperation
  • 12/1/2020LianBio Cleared for Phase 2a Trial of Anticancer Infigratinib in China
  • 12/1/2020Mind The Gap - The IP Protection Law vs. Reality in China
  • 12/1/2020MNCs Renew Commitments at CIIE as China Pushes Telemedicine and Specia...
  • 11/30/2020China's New Export Control Law Triggers More Trade and Investment Comp...
  • 11/30/2020Junshi Biosciences Announces NMPA Acceptance of Its IND for JS006
  • 11/29/2020Ascentage In-licenses UM's MDM2 Degrader Developed Using PROTAC Tech...
  • 11/29/2020CDE Issues the Guidelines for Use of GnRH Stimulants in Clinical Trial...
  • 11/29/2020CDE Issues the Technical Guidelines for Clinical Trial Endpoints for L...
  • 11/27/2020Financial-related Company News in Brief
  • Page:224/789 Total number of articles:23668: [First][<<] [222] [223] [224] [225] [226] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group